IPHA CIK: 1598599

Innate Pharma SA

  • France
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions EUR
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions EUR
FY21:
−47.8
FY22:
−57.4
FY23:
−12.7
FY24:
−51.6
FY25:
−54.0
(positive)
Change from FY21 to FY25
millions EUR
FY21:
−45.5
FY22:
−58.0
FY23:
−7.57
FY24:
−49.5
FY25:
−49.2
(positive)
Change from FY21 to FY25
millions EUR
FY21:
−52.8
FY22:
−58.1
FY23:
−7.57
FY24:
−49.5
FY25:
−49.2

All amounts in millions EUR Data source:SEC EDGAR